Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT1A receptor

被引:25
作者
Costa-Neto, CM
Mikakawa, AA
Oliveira, L
Hjorth, SA
Schwartz, TW
Paiva, ACM
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 Sao Paulo, Brazil
[2] Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Copenhagen, Denmark
关键词
angiotensin II; AT(1) receptor; G-protein; site-directed mutagenesis;
D O I
10.1038/sj.bjp.0703430
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The role of different residues of the rat AT(1A) receptor in the interaction with the N- and C-terminal ends of angiotensin II (AngII) was studied by determining ligand binding and production of inositol phosphates (IP) in COS-7 cells transiently expressing the following AT(1A) mutants: T88H, Y92H, G196I, G196W and D278E. 2 G196W and G196I retained significant binding and IF-production properties, indicating that bulky substituents in position 196 did not affect the interaction of AngII's C-terminal carboxyl with Lys(199) located three residues below. 3 Although the T88A mutation did not affect binding, the T88H mutant had greatly decreased affinity for AngII, suggesting that substitution of Thr(88) by His might hinder binding through an indirect effect. 4 The Y92H mutation caused loss of affinity for AngII that was much less pronounced than that reported for Y92A, indicating that His in that position can fulfil part of the requirements for binding. 5 Replacing Asp(278) by Glu caused a much smaller reduction in affinity than replacing it by Ala, indicating the importance of Asp's beta-carboxyl group for AngII binding. 6 Mutations in residues Thr(88), Tyr(92) and Asp(278) greatly reduced affinity for AngII but not for Sar(1) Leu(8)-AngII, suggesting unfavourable interactions between these residues and AngII's aspartic acid side-chain or N-terminal amino group, which might account for the proposed role of the N-terminal amino group of AngII in the agonist-induced desensitization (tachyphylaxis) of smooth muscles.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 21 条
[1]   CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES [J].
BERRIDGE, MJ ;
DAWSON, RMC ;
DOWNES, CP ;
HESLOP, JP ;
IRVINE, RF .
BIOCHEMICAL JOURNAL, 1983, 212 (02) :473-482
[2]   MUTATION OF ASP(74) OF THE RAT ANGIOTENSIN-II RECEPTOR CONFERS CHANGES IN ANTAGONIST AFFINITIES AND ABOLISHES G-PROTEIN COUPLING [J].
BIHOREAU, C ;
MONNOT, C ;
DAVIES, E ;
TEUTSCH, B ;
BERNSTEIN, KE ;
CORVOL, P ;
CLAUSER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5133-5137
[3]   Ab initio modeling and molecular dynamics simulation of the α1b-adrenergic receptor activation [J].
Fanelli, F ;
Menziani, C ;
Scheer, A ;
Cotecchia, S ;
De Benedetti, PG .
METHODS, 1998, 14 (03) :302-317
[4]  
FENG Y, 1995, J BIOL CHEM, V170, P12846
[5]  
GETHER U, 1993, J BIOL CHEM, V268, P7893
[6]   Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction [J].
Han, HMCB ;
Shimuta, SI ;
Kanashiro, CA ;
Oliveira, L ;
Han, SW ;
Paiva, ACM .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (06) :810-814
[7]  
HJORTH SA, 1994, J BIOL CHEM, V269, P30953
[8]   Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor [J].
Holst, B ;
Zoffmann, S ;
Elling, CE ;
Hjorth, SA ;
Schwartz, TW .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :166-175
[9]   ENGINEERING HYBRID GENES WITHOUT THE USE OF RESTRICTION ENZYMES - GENE-SPLICING BY OVERLAP EXTENSION [J].
HORTON, RM ;
HUNT, HD ;
HO, SN ;
PULLEN, JK ;
PEASE, LR .
GENE, 1989, 77 (01) :61-68
[10]   BIOSYNTHESIS OF PEPTIDE PRECURSORS AND PROTEASE INHIBITORS USING NEW CONSTITUTIVE AND INDUCIBLE EUKARYOTIC EXPRESSION VECTORS [J].
JOHANSEN, TE ;
SCHOLLER, MS ;
TOLSTOY, S ;
SCHWARTZ, TW .
FEBS LETTERS, 1990, 267 (02) :289-294